Pushing Pharmaceutical Innovation Forward

By: Jen Hilderbrand

As a mother,  this year has been really difficult for my family as I’m sure it has been for millions of others. School closures, cancelled youth sports, and countless other kid friendly activities being called off or indefinitely delayed due to COVID-19 has put a real strain on both my husband and I and our children. 

These challenges are why I have been so encouraged to see positive vaccine news coming from America’s pharmaceutical industry. With three promising vaccine candidates on the way and 2020 coming to an end, I have hope that we will be able to get back to some semblance of normal in 2021. 

However, the pandemic has also put a spotlight on our health care industry once again, specifically highlighting the critical nature of continued scientific innovation. Most of us did not realize the billions of dollars, years of trial and error, and the immense intellectual resources  required to develop a new medication. 

But, thanks to 2020, we all know what it takes, and my hope is that this new knowledge will cause consumers and legislators alike to prioritize future research and development. 

It is clear, in order to build the most sustainable and healthy America possible we need to invest in new treatments and cures. This means passing new policies that cut regulatory red tape at the FDA and avoiding government price setting policies that stand to undercut funding for research. 

I hope others, especially our legislators, will remember the importance of pushing pharmaceutical innovation forward once we move past COVID-19.

###


Leave a Reply